The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface
Open accessAbstract
Prostate cancer is a leading killer of men in the industrialized world. Underlying this disease is the aberrant action of the androgen receptor (AR). AR is distinguished from other nuclear receptors in that after hormone binding, it preferentially responds to a specialized set of coactivators bearing aromatic-rich motifs, while responding poorly to coactivators bearing the leucine-rich "NR box" motifs favored by other nuclear receptors. Under normal conditions, interactions with these AR-specific coactivators through aromatic-rich motifs underlie targeted gene transcription. However, during prostate cancer, abnormal association with such coactivators, as well as with coactivators containing canonical leucine-rich motifs, promotes disease progression. To understand the paradox of this unusual selectivity, we have derived a complete set of peptide motifs that interact with AR using phage display. Binding affinities were measured for a selected set of these peptides and their interactions with AR determined by X-ray crystallography. Structures of AR in complex with FxxLF, LxxLL, FxxLW, WxxLF, WxxVW, FxxFF, and FxxYF motifs reveal a changing surface of the AR coactivator binding interface that permits accommodation of both AR-specific aromatic-rich motifs and canonical leucine-rich motifs. Induced fit provides perfect mating of the motifs representing the known family of AR coactivators and suggests a framework for the design of AR coactivator antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., & Peeters, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6085 · Cited by 268
Langley, E., Kemppainen, J. A., & Wilson, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.92 · Cited by 233
Geistlinger, T. R., & Guy, R. K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0348391 · Cited by 94
Hsu, C.-L., Chen, Y.-L., Yeh, S., Ting, H.-J., Hu, Y.-C., Lin, H., Wang, X., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211908200 · Cited by 85
Research works printed but not linked: 30
- Asada, 2003, J Am Chem Soc, 125, 4992, 10.1021/ja0292703 · DOI
- Bledsoe, 2002, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6 · DOI · Paper page
- Brunger, 1998, Acta Crystallogr D Biol Crystallogr, 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
- Chang, 1999, Mol Cell Biol, 19, 8226, 10.1128/MCB.19.12.8226 · DOI · Paper page
- Culig, 2002, Endocr Relat Cancer, 9, 155, 10.1677/erc.0.0090155 · DOI · Paper page
- Darimont, 1998, Genes Dev, 12, 3343, 10.1101/gad.12.21.3343 · DOI · Paper page
- Ding, 1998, Mol Endocrinol, 12, 302, 10.1210/mend.12.2.0065 · DOI · Paper page
- Gottlieb, 1998, Nucleic Acids Res, 26, 234, 10.1093/nar/26.1.234 · DOI
- Gregory, 2001, Cancer Res, 61, 4315
- He, 2003, Mol Cell Biol, 23, 2135, 10.1128/MCB.23.6.2135-2150.2003 · DOI
- He, 1999, J Biol Chem, 274, 37219, 10.1074/jbc.274.52.37219 · DOI · Paper page
- He, 2000, J Biol Chem, 275, 22986, 10.1074/jbc.M002807200 · DOI · Paper page
- He, 2002a, J Biol Chem, 277, 25631, 10.1074/jbc.M202809200 · DOI · Paper page
- He, 2002b, J Biol Chem, 277, 10226, 10.1074/jbc.M111975200 · DOI · Paper page
- Kleywegt, 1996, Acta Crystallogr D Biol Crystallogr, 52, 842, 10.1107/S0907444995016477 · DOI · Paper page
- Lee, 2003, Cell Mol Life Sci, 60, 1613, 10.1007/s00018-003-2309-3 · DOI · Paper page
- Matias, 2000, J Biol Chem, 275, 26164, 10.1074/jbc.M004571200 · DOI · Paper page
- Needham, 2000, J Steroid Biochem Mol Biol, 72, 35, 10.1016/S0960-0760(00)00027-3 · DOI
- Newmark, 1992, Proc Natl Acad Sci U S A, 89, 6319, 10.1073/pnas.89.14.6319 · DOI · Paper page
- Nolte, 1998, Nature, 395, 137, 10.1038/25931 · DOI · Paper page
- Norris, 1999, Science, 285, 744, 10.1126/science.285.5428.744 · DOI · Paper page
- Northrop, 2000, Mol Endocrinol, 14, 605
- Paige, 1999, Proc Natl Acad Sci U S A, 96, 3999, 10.1073/pnas.96.7.3999 · DOI · Paper page
- Quigley, 1995, Endocr Rev, 16, 271
- Sack, 2001, Proc Natl Acad Sci U S A, 98, 4904, 10.1073/pnas.081565498 · DOI · Paper page
- Shiau, 1998, Cell, 95, 927, 10.1016/S0092-8674(00)81717-1 · DOI · Paper page
- Slagsvold, 2000, Mol Endocrinol, 14, 1603, 10.1210/mend.14.10.0544 · doi:10.1210/mend.14.10.0544
- Wang, 2001, J Biol Chem, 276, 7493, 10.1074/jbc.M009916200 · DOI
- Warnmark, 2001, J Biol Chem, 276, 23397, 10.1074/jbc.M011651200 · DOI
- Warnmark, 2002, J Biol Chem, 277, 21862, 10.1074/jbc.M200764200 · DOI · Paper page
Cited by
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533
Chemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528
Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery
Gentile, F., Agrawal, V., Hsing, M., Ton, A.-T., Ban, F., Norinder, U., Gleave, M. E., & Cherkasov, A. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00229 · Cited by 447
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
Bohl, C. E., Gao, W., Miller, D. D., Bell, C. E., & Dalton, J. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500381102 · Cited by 421
Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397
Yuan, X., Cai, C., Chen, S., Chen, S., Yu, Z., & Balk, S. P. (2014) · Oncogene · doi:10.1038/onc.2013.235 · Cited by 370
The structures of type I polyketide synthases
Keatinge-Clay, A. T. (2012) · Natural Product Reports · doi:10.1039/c2np20019h · Cited by 344
RBR E3 ubiquitin ligases: new structures, new insights, new questions
Spratt, D. E., Walden, H., & Shaw, G. S. (2014) · Biochemical Journal · doi:10.1042/bj20140006 · Cited by 315
A surface on the androgen receptor that allosterically regulates coactivator binding
Estébanez-Perpiñá, E., Arnold, L. A., Nguyen, P., Rodrigues, E. D., Mar, E., Bateman, R., Pallai, P., Shokat, K. M., Baxter, J. D., Guy, R. K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708036104 · Cited by 307
Self-citationMolecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Pereira de Jésus‐Tran, K., Côté, P., Cantin, L., Blanchet, J., Labrie, F., & Breton, R. (2006) · Protein Science · doi:10.1110/ps.051905906 · Cited by 278
Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
Ravindranathan, P., Lee, T.-K., Yang, L., Centenera, M. M., Butler, L., Tilley, W. D., Hsieh, J.-T., Ahn, J.-M., & Raj, G. V. (2013) · Nature Communications · doi:10.1038/ncomms2912 · Cited by 257
Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer
Dehm, S. M., & Tindall, D. J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0223 · Cited by 253
Lavery, D. N., & Mcewan, I. J. (2005) · Biochemical Journal · doi:10.1042/bj20050872 · Cited by 227
The role of androgen receptor mutations in prostate cancer progression.
Brooke, G., & Bevan, C. (2009) · Current Genomics · doi:10.2174/138920209787581307 · Cited by 181
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Yu, X., Yi, P., Hamilton, R. A., Shen, H., Chen, M., Foulds, C. E., Mancini, M. A., Ludtke, S. J., Wang, Z., & O’Malley, B. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.031 · Cited by 154
Stepwise androgen receptor dimerization
van Royen, M. E., van Cappellen, W. A., de Vos, C., Houtsmuller, A. B., & Trapman, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.096792 · Cited by 143
Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
Kumar, R., & McEwan, I. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1033 · Cited by 135
Androgen receptor coregulators: recruitment via the coactivator binding groove
van de Wijngaart, D. J., Dubbink, H. J., van Royen, M. E., Trapman, J., & Jenster, G. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.007 · Cited by 122
Dehm, S. M., Regan, K. M., Schmidt, L. J., & Tindall, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1267 · Cited by 84
Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
Tsai, J. M., Aguirre, J. D., Li, Y.-D., Brown, J., Focht, V., Kater, L., Kempf, G., Sandoval, B., Schmitt, S., Rutter, J. C., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.028 · Cited by 68
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif
Jehle, K., Cato, L., Neeb, A., Muhle-Goll, C., Jung, N., Smith, E. W., Buzon, V., Carbó, L. R., Estébanez-Perpiñá, E., Schmitz, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534859 · Cited by 53
“Previous studies to identify sequences on coactivators that bind the LBD of nuclear receptors using phage display libraries have only identified variants of the LXXLL motif (11, 47).”
BackgroundInfluentialDubbink, H. J., Hersmus, R., Pike, A. C. W., Molier, M., Brinkmann, A. O., Jenster, G., & Trapman, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0348 · Cited by 47
Metadata
- Authors
- Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-08-24
- Volume
- 2
- Issue
- 9
- Pages
- e274
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- OpenAlex
- W2151286904
- Cited by
- 234
- References
- 6
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.